Table 1.
Cytokines and immune cells in islets of patients with T2D
Islet source | Sample size | Method | Immune cells | Cytokines | Ref. |
---|---|---|---|---|---|
Pancreas sections | 5 T2D |
Immuno-histochemistry In situ hybridization |
n.a. | IL-1β↑ (22.5% of islets from T2D were positive) | [8] |
Pancreas sections |
9 T2D 7 controls |
Immuno-histochemistry |
CD68+↑ CD3+ T- cells→ Granulocytes→ |
n.a. | [9] |
β-cell enriched samples isolated by LCM of pancreas sections |
10 T2D 9 controls |
Gene array qPCR | n.a. |
IL-1β: gene array↑ qPCR↑ IL-8: gene array↑ qPCR↑ (n.s.) |
[10] |
Pancreas section of T2D patients |
15 T2D 16 controls |
Immuno-histochemistry | CD68+↑ | n.a. | [11] |
β-cell enriched samples isolated by LCM of pancreas sections |
10 T2D 10 controls |
Gene array Immuno-histochemistry of CCL2 |
n.a. |
CCL13, CCL2↑ IL-1β, IL-8, CCL11, CXCL1, IL6↑ (n.s.) |
[12] |
Isolated islets |
10 T2D 38 controls |
Gene array, co-expression networks | n.a. | IL6, IL11, IL33, IL13RA2, IL18R1, IL1R1, IL1R2, IL1RL1↑ | [13] |
Pancreas sections |
20 T2D no amyloid 26 with amyloid 20 controls |
Immuno-histochemistry |
CD68+↑ selectively in amyloid + samples and not in amyloid − samples CD163+→ |
n.a. | [14] |
Isolated islets cultured for ≅ 3 days |
18 T2D 21 controls |
FACS islet function |
CD45+↑ CD3+ T-cells→ CD20+ B-cells↑ |
CCL2, TNF-α↑ | [15] |
Pancreas sections |
11 T2D 15 controls |
Immuno-histochemistry | CD8+ T-cells↑ (only in exocrine tissue) | n.a. | [16] |
Pancreas sections |
7 T2D 7 controls |
Electron-microscopy |
Macrophages↑ Lymphocytes→ Mast cells→ |
n.a. | [17] |
Isolated islets |
4 T2D 6 controls |
Single cell RNAseq | n.a. | Cytokine signaling in acinar cells↑ | [18] |
Pancreas sections |
17 T2D 16 controls |
Immuno-histochemistry | CD45+↑ | n.a. | [19] |
Pancreas sections |
50 T2D 44 controls |
Immuno-histochemistry |
28% T2D with insulitis CD45+ (endo- and exocrine)↑ |
n.a. | [20] |
Isolated islets SR and LCM of β-cell enriched samples |
Islets: 19 T2D 84 controls SR: 36 T2D 32 controls |
Gene array | n.a. |
Islets: IL-1β, CCL26, CCL3, CCL8, CXCL1, CXCL11, CXCL12, CXL2, CXCR7↑ SR→ |
[21] |
Ref. reference; LCM laser capture microdissection; n.a. not analyzed; SR surgical resection
↑ significantly increased; → unchanged; ↑ (n.s) trend to increase, not significant